SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-045283
Filing Date
2024-04-09
Accepted
2024-04-09 17:26:12
Documents
16
Period of Report
2024-04-09
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2411445d1_8k.htm   iXBRL 8-K 43952
2 EXHIBIT 99.1 tm2411445d1_ex99-1.htm EX-99.1 10834
6 GRAPHIC tm2411445d1_ex99-1img001.jpg GRAPHIC 11199
7 GRAPHIC tm2411445d1_ex99-1img002.jpg GRAPHIC 3558
  Complete submission text file 0001104659-24-045283.txt   256565

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA jagx-20240409.xsd EX-101.SCH 3045
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE jagx-20240409_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE jagx-20240409_pre.xml EX-101.PRE 22379
19 EXTRACTED XBRL INSTANCE DOCUMENT tm2411445d1_8k_htm.xml XML 3682
Mailing Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104
Business Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104 415-371-8300
Jaguar Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36714 | Film No.: 24833643
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)